fah hospital policy blog

Perspectives on health policy affecting America’s hospitals and the patients we serve.

New Report Shows Impact of Rising Drug Prices and Drug Shortages on Patients and Hospitals

January 15, 2019 | FAH Policy Blog Team

Category: Pharmaceuticals, Research

Today, the Federation of American Hospitals (FAH), the American Hospital Association (AHA), and the American Society of Health-System Pharmacists (ASHP) released a new report finding that continued rising drug prices, as well as shortages for many critical medications, are impacting patient care and putting strains on hospital budgets and operations. The report was prepared based on analysis conducted by NORC at the University of Chicago, an independent research institution.

Read More »

FAH Leader Expresses Opposition to Ruling that Overturns 340B Medicare Regulation

January 02, 2019 | Chip Kahn

Category: Financing, Medicare, Pharmaceuticals

The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer payments.

Read More »

FAH, AHA Send Joint Letter to Congress on Surprise Billing

December 21, 2018 | FAH Policy Blog Team

Category: Financing, Health Care Delivery

This afternoon FAH President and CEO Chip Kahn and AHA President and CEO Rick Pollack sent a joint letter to leaders in Congress addressing the issue of surprise billing highlighting the need to find a solution that first and foremost protects patients.

Read More »

FAH Comments on Proposed Rule Expanding Use of HRAs

December 21, 2018 | FAH Policy Blog Team

Category: Financing

Today, the FAH commented on the Administration’s proposal to expand the use of health reimbursement arrangements (HRAs). Under the proposal, employers would be allowed to reimburse their employees through the use of a HRA for purchase of individual coverage.

Read More »